$RPRX Royalty Pharma plc Insider Trading
Get free email notifications about insider trading in Royalty Pharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Royalty Pharma plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Royalty Pharma plc for free.
CIK Number: 0001802768
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RPRX
Company Address: 110 EAST 59TH STREET NEW YORK 10022
Royalty Pharma plc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2021 | RPRX | Royalty Pharma plc | LOVE TED W | Director | Grant | A | 0.00 | 5,726 | 0 | 22,866 | 17.1 K to 22.9 K (+33.41 %) |
Jun 29 2021 | RPRX | Royalty Pharma plc | LOVE TED W | Director | Grant | A | 0.00 | 5,726 | 0 | 22,866 | 17.1 K to 22.9 K (+33.41 %) |
Jun 29 2021 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 5,726 | 0 | 50,370 | 44.6 K to 50.4 K (+12.83 %) |
Jun 29 2021 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 5,726 | 0 | 50,370 | 44.6 K to 50.4 K (+12.83 %) |
Jun 29 2021 | RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Grant | A | 0.00 | 5,726 | 0 | 15,115 | 9.4 K to 15.1 K (+60.99 %) |
Jun 29 2021 | RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Grant | A | 0.00 | 5,726 | 0 | 15,115 | 9.4 K to 15.1 K (+60.99 %) |
Jun 04 2021 | RPRX | Royalty Pharma plc | Urist Marshall | EVP & Co-Head Resea ... | Sell | S | 41.52 | 14,566 | 604,850 | 33,134 | 47.7 K to 33.1 K (-30.54 %) |
Jun 04 2021 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Sell | S | 42.13 | 50,000 | 2,106,385 | 1,050,000 | 1.1 M to 1.1 M (-4.55 %) |
Jun 04 2021 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Sell | S | 42.09 | 12,500 | 526,128 | 713,360 | 725.9 K to 713.4 K (-1.72 %) |
May 11 2021 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Option Exercise | C | 0.00 | 100,000 | 0 | 22,945 | |
May 11 2021 | RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Buy | C | 0.00 | 1,000,000 | 0 | 1,000,000 | 0 to 1000 K |
May 11 2021 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | C | 0.00 | 30,000 | 0 | 264,027 | |
May 11 2021 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | C | 0.00 | 90,000 | 0 | 172,680 | |
May 11 2021 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Option Exercise | C | 0.00 | 67,586 | 0 | 0 | |
May 11 2021 | RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & ... | Buy | C | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |